Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRent ExpenseResearch & DevelopmentRestructuring CostsRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Quipt Home Medical (QIPT) Research & Development (2023 - 2025)

Historic Research & Development for Quipt Home Medical (QIPT) over the last 3 years, with Q4 2025 value amounting to $682000.0.

  • Quipt Home Medical's Research & Development rose 6593.67% to $682000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $2.2 million, marking a year-over-year increase of 3724.77%. This contributed to the annual value of $2.0 million for FY2025, which is 2386.93% up from last year.
  • As of Q4 2025, Quipt Home Medical's Research & Development stood at $682000.0, which was up 6593.67% from $541000.0 recorded in Q3 2025.
  • Over the past 5 years, Quipt Home Medical's Research & Development peaked at $682000.0 during Q4 2025, and registered a low of $368000.0 during Q4 2023.
  • In the last 3 years, Quipt Home Medical's Research & Development had a median value of $435000.0 in 2024 and averaged $471888.9.
  • In the last 5 years, Quipt Home Medical's Research & Development surged by 1168.48% in 2024 and then skyrocketed by 6593.67% in 2025.
  • Quarter analysis of 3 years shows Quipt Home Medical's Research & Development stood at $368000.0 in 2023, then grew by 11.68% to $411000.0 in 2024, then skyrocketed by 65.94% to $682000.0 in 2025.
  • Its Research & Development stands at $682000.0 for Q4 2025, versus $541000.0 for Q3 2025 and $564000.0 for Q2 2025.